Posts by vgn1
Global Virus Network (GVN) Catalyzes World Health Organization (WHO) to Officially Recognize HTLV-1 as Threatening Pathogen to Humans
March 29, 2021 During GVN’s 9th International Meeting in Melbourne, Australia on September 25-27, 2017 in partnership with the Peter Doherty Institute and the Institut Pasteur, researchers held impressive sessions on one of the most potent human carcinogens, human T cell leukemia virus-1 (HTLV-1). The sessions were organized by Dr. Sharon Lewin, Director of The…
Read MoreCorrelates of Protection
Role of Correlates of Protection, or Immune Measurements, in Predicting Protective Immunity of COVID-19 Vaccines March 29, 2021 Broadly speaking, correlates of protection are measurements of immune parameters that allow prediction of the degree of protection against infection or disease induced by a pathogen. A prime point of interest in consideration of protection against SARS-CoV-2…
Read MoreGLOBAL VIRUS NETWORK (GVN) ADDS SANOFI PASTEUR TO GVN HEALTHCARE & PHARMA CENTERS OF EXCELLENCE COALITION
The Partnership Focuses on Training The Next Generation of Virus Researchers to Safeguard Mankind from Current and Future Threats Baltimore, Maryland, USA, March 23, 2021: The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research response, by training…
Read MoreGlobal Virus Network (GVN) Adds Renowned Institut Pasteur Korea (IPK) to Combat Viral Diseases
Baltimore, Maryland, USA, March 22, 2021: The Global Virus Network (GVN), representing 62 Centers of Excellence and 11 Affiliates in 34 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut Pasteur Korea (IPK) announced today the addition of the IPK as GVN’s newest Center of Excellence. “We are…
Read MorePregnancy and COVID-19 Vaccines
Pregnancy and COVID-19 Vaccines March 5, 2021 While the COVID-19 vaccination program is extending globally, we have many questions regarding the vaccines’ safety, durability, and efficacy against variants. One of the important safety questions is the effects of COVID-19 vaccines on pregnant women as clinical trials for COVID-19 vaccines were conducted without their participation. Are…
Read MorePhilanthropist Donates US$1 Million to Global Virus Network: Anonymous Gift Will Support Educational & Training Initiatives
Largest Gift In The Organization’s History Coincides With The Tenth Anniversary of the Founding of the Global Virus Network Baltimore, Maryland, USA, March 2, 2021: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working to prevent illness and death from viral disease, today announced the donation of US$1…
Read MoreShould the Global Community Be Concerned About the South African Variant?
Should the Global Community Be Concerned About the South African Variant? February 23, 2021 Currently, the downward trend of SARS-CoV-2 infections per day in the U.S. is continuing, and the case numbers of COVID-19 are less than half of what it was at the peak of the pandemic (Worldometers).The mortality rate of COVID-19 is also…
Read MoreGlobal Virus Network Names USF Health the GVN Southeast U.S. Regional Headquarters
Baltimore, Maryland, USA (Feb. 23, 2021) — The Global Virus Network (GVN), a coalition comprising the world’s foremost experts in every class of virus causing disease in humans and some animals, today announced that USF Health, at the University of South Florida (USF) in Tampa, Fla., will serve as GVN’s Southeast United States Regional Headquarters. USF…
Read MoreCOVID-19 and Autoimmunity
COVID-19 and Autoimmunity Are Severe Cases of COVID-19 Related to an Autoimmune Disease? February 15, 2021 COVID-19, the disease caused by SARS-CoV-2, involves at least two distinct phases. The first phase is attributed to typical progress of respiratory disease by causing fever, cough, loss of taste/smell, and other symptoms typical of respiratory infections. The second…
Read MoreUpdate on SARS-CoV-2 Variants
Update on SARS-CoV-2 Variants Efficient Vaccine Distribution is Critical to Mitigate the Continuing Evolution of SARS-CoV-2 February 5, 2021 We’ve recently reported on SARS-CoV-2 variants, and described some of the reasons for concern. These include increased transmissibility, the possibility of false negative tests for viral RNA, resistance to immune protection from vaccine or prior infection,…
Read More